Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FQHCR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,045
Award facts
- Contract value 100% obligated
- $32,044.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,044.80 delivery order to AmerisourceBergen Drug Corp for KESIMPTA 20 MG/0.4 ML pen injectors on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
KESIMPTA is a specialty medication used in the treatment of neurological conditions, reflecting the scope of therapeutically diverse pharmaceutical products that AmerisourceBergen provides through its federal medical supply contracts. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills delivery orders through the DLA Troop Support Medical contract to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its capability to meet rigorous federal procurement standards for pharmaceutical product delivery.
Quick answers
Who was awarded contract SPE2DB25FQHCR?
SPE2DB25FQHCR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FQHCR worth?
The government has obligated $32,045 on SPE2DB25FQHCR.
Is contract SPE2DB25FQHCR an order under another contract?
Yes. SPE2DB25FQHCR is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHCR competed?
The extent of competition for SPE2DB25FQHCR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award